JFS WEALTH ADVISORS, LLC - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 189 filers reported holding REATA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 2.52 and the average weighting 0.3%.

Quarter-by-quarter ownership
JFS WEALTH ADVISORS, LLC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$204
-89.8%
2
-91.7%
0.00%
Q3 2021$2,000240.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
CPMG Inc 2,896,901$110,053,26927.64%
Ghost Tree Capital, LLC 500,000$18,995,0008.11%
First Light Asset Management, LLC 2,062,453$78,352,5897.27%
Boxer Capital, LLC 1,230,004$46,727,8522.46%
Sofinnova Investments, Inc. 992,029$37,687,1822.24%
Tri Locum Partners LP 141,466$5,374,0002.17%
MPM BioImpact LLC 194,181$7,376,9361.91%
Ikarian Capital, LLC 201,200$7,643,5881.84%
KRS Capital Management, LLC 28,141$1,069,0771.46%
EMERALD ADVISERS, LLC 679,772$25,824,5381.25%
View complete list of REATA PHARMACEUTICALS INC shareholders